In Aug 2020, during the first attempt at FDA approval MSB reached a market cap of $3.1B on 585m ord shares.
The attached chart is how I see the range as the company approaches re-submission albeit with a few additional catalysts and shares obviously.
MSB's market cap is regaining territory on its valuation which currently sits at just over A$1B
Look for a huge green monthly candles in this qtr IMO
GLTA
Valuation, page-7
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.083(8.51%) |
Mkt cap ! $1.196B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $3.756M | 3.656M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 16092 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.06 | 144405 | 20 |
View Market Depth
| Last trade - 14.01pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |